The preponderance of evidence supports an aryl hydrocarbon receptor-dependent mechanism of action of tapinarof
J Am Acad Dermatol
.
2021 Jul;85(1):e35-e36.
doi: 10.1016/j.jaad.2021.03.005.
Epub 2021 Mar 4.
Authors
Robert Bissonnette
1
,
Linda Stein Gold
2
,
David S Rubenstein
3
,
Anna M Tallman
4
,
April W Armstrong
5
Affiliations
1
Innovaderm Research Inc, Montreal, Quebec, Canada. Electronic address: rbissonnette@innovaderm.com.
2
Henry Ford Health System, Detroit, Michigan.
3
Dermavant Sciences, Inc, Durham, North Carolina.
4
Dermavant Sciences Inc, Long Beach, California.
5
Keck School of Medicine of the University of Southern California, Los Angeles, California.
PMID:
33677005
DOI:
10.1016/j.jaad.2021.03.005
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Receptors, Aryl Hydrocarbon* / genetics
Resorcinols
Stilbenes*
Substances
Receptors, Aryl Hydrocarbon
Resorcinols
Stilbenes
tapinarof